Melhoidosis, an infectious disease caused by Pseudomonas pseudomallei, is endemic to Southeast Asia. It has been increasingly recognized in U.S. Armed Forces personnel who have served in South Vietnam (1, 3, 6, 17, 20) . The disease signs are not pathognomonic. Manifestations may range from a mild subacute disease with localized lesions to a rapidly fatal septicemic form. Dormant or inapparent infections occur and may recrudesce in severe fulminant form months and even years after exposure (4, 14) . The IHA test. The IHA test was a modification of the procedure described by Ileri (8) . The test was initially conducted in hemagglutination test tubes and later adapted for use with the microtiter technique. The sensitivity and specificity of the two techniques were found to be essentially the same when comparative tests were done on 50 sera, equally derived from known infected and normal human beings. Details on the preparation and standardization of antigen, preparation of sensitized sheep cells, and conduct of tube IHA test were reported previously (18) . Generally, antigen for each of the three strains was prepared by the method of Rice et al. (15) , and consisted of the supernatant fluid of a heat-killed 2-week-old proteinfree broth culture. The antigen was preserved by addition of phenol (0.5%i by volume) and was stored at 4 C. Antigens have maintained their activity over a 3-year observation period. Optimum dilutions of each antigen for sensitizing sheep red blood cells were predetermined by appropriate block titrations of reference antiserum and antigen and pooled in equal volumes. An anti-P. pseudomallei rabbit serum was first used as a reference antiserum and later replaced with a high-titer convalescent serum from a proved human case of melioiodosis. The (13) . Antigens from three strains were prepared separately, and predetermined optimum dilutions were pooled in equal volumes to provide the test antigen. Each strain was grown on the surface of brain-heart infusion agar (pH 6.8) in ten 32-oz prescription bottles, each of which was seeded with 2.0 ml of a heavy suspension of organisms. The seed suspension was prepared from the 24-to 48-hr smooth confluent growth on a petri plate culture. After 48 hr of incubation at 35 to 37 C, growth in each bottle was suspended in 20 ml of sterile distilled water, subcultured for purity determinations, and stored at 4 C. If cultural tests were satisfactory, suspensions were pooled. The pooled suspension was standardized spectrophotometrically to a density of approximately 14 X 109 cells/ml by optical density (OD) measurements at 610 ,ug of appropriate dilutions and reference to a previously determined standard curve relating bacterial counts to OD. The standardized suspensions were inactivated by heating in a 65 C water bath for 1 hr, and then subcultured for sterility determinations and stored at 4 C. Subcultures were incubated for 4 days at 35 C to ascertain the absence of viable organisms in the heattreated cell suspension. Cells were disrupted by subjecting 70-ml amounts of standardized cell suspension, in a 125-mi oscillator cup, to sonic vibration at a frequency of 20 kc/sec for 10 min in a 4 C water-cooled oscillator (Biosonek) at a maximum output of 600 w. The sonically treated suspensions were centrifuged in a 4 C refrigerated centrifuge at 18,000 X g for 30 min, and the supernatant fluid was collected. The sediment was resuspended in water to one-fourth of the original volume of the standardized suspension and centrifuged, and the supernatant fluid was combined with that of the first centrifugation. The combined supernatant fluids were successively filtered through 0.8-to 1.2-Mm and 0.22-or 0.45-,um pore size sterile filters (Millipore Corp., Bedford, Mass.). The filtered supernatant fluids, which constituted the stock CF antigen, were distributed in sterile vaccine bottles and stored at 4C. Stored antigens have remained stable over a 3-year observation period.
The procedures described by Kent and Fife (9) were followed for preparation and standardization of sheep erythrocytes and standardization of complement, hemolysin, and antigen. The reagent diluent was triethanolamine-buffered salt solution. One liter of stock solution (lOX concentrated) contains 75 g of NaCl, 28 ml of N(CH2CH20H)3, 170 ml of 1 N HCl, 1 g of MgCl2.6H20, and 0.2 g of CaCl2-2H20. The optimum dilution of P. pseudomallei antigen for conducting the test varied from 1:100 to 1: 300. Reference antisera were the same as those used for IHA tests.
Test sera were inactivated at 56 C for 30 min and serially diluted twofold from 1:4 through 1:64 or greater if necessary. To 0.3 ml of diluted serum, 0.3 ml of a solution containing five (50%) hemolytic units of complement and 0.3 ml of pooled antigen were added in a standard Wasserman tube. Mixtures were held at 2 to 4 C for 16 hr and then warmed to room temperature, and 0.6 ml of sensitized sheep erythrocytes was added. Test tubes were held at 37 C for 30 min and then examined. Results were recorded in terms of degree of fixation from negative to 4+. The titer was the highest dilution of serum with a 2+ (e.g., 50% hemolysis) or greater reaction. Tables 7 and 8 , respectively. When more than one serum from a patient was tested in a specified time interval, findings on only one of the specimens were tabulated. Differences in titer of such multiple specimens usually were not greater than twofold. Positive IHA and CF reactions, frequently at high titer, were seen in 38 to 71 % of samples obtained during the first week of disease. Within time intervals from 2 weeks to 9 months after disease onset, detectable antibodies were demonstrated by IHA tests in 88 to 100%, and by CF tests in 93 to lOO1o of the samples.
High titers were usually attained by the third week of disease. Titers persisted for 9 months or longer. In this series, peak geometric mean IHA titer of 1:816 and CF titer of 1:99 were seen during the 4th to 5th month after disease onset.
Thirty-one patients provided samples 9 months or more after disease onset. P. pseudomallei was isolated from all but 5 (8, 10) , and CF tests conducted with sonically treated (12) or aqueous extracts of organisms (2, 10, 11) appeared to be promising serological diagnostic tools. The factors which led to our selection of the IHA test of Ileri (8) and the described CF test were safety and simplicity in preparation of antigens, the ready applicability of the tests by diagnostic laboratories, and favorable preliminary findings on sensitivity and specificity of the tests. Minor modifications of the IHA test were made to improve the standardization of reagents.
In our experience, the described IHA and CF tests were valuable tools for diagnosis of human cases of melioidosis. The IHA and CF tests served to demonstrate significant antibodies, respectively, in 97%, of 112 and 99% of 117 culturally proved cases when paired or serial serum samples were tested. In approximately 19% of 94 culturally proved cases, transient seronegative reactions during the course of disease were seen with either IHA of CF tests, but rarely with both tests. Negative and low-titer reactions in proved cases could not be related to possible antigenic differences among strains. Variable negative and positive serological reactions occurred more frequently with the IHA procedure and were demonstrated more often in cases with localized formsof disease. Similar discrepant serological findings in human melioidosis were also reported by Fournier et al. (5) .
The CF and IHA test findings on 445 sera from 114 patients, from whom P. pseudomallei was isolated, correlated 87%. The CF test appeared to be slightly more sensitive. Both IHA and CF tests had excellent specificity when evaluated with sera from normal human beings. However, the high specificity of the CF test was not affirmed when tests were done with diverse antibacterial sera from hyperimmunized rabbits and from human patients. The CF antigen appeared to contain a common antigen with some but not all types of P. aeruginosa. In tests on nonmelioidosis patients, the CF test elicited reactions in sera from 5 of 11 patients with P. aeruginosa or P. stutzeri infections, but only in 7 sera from 96 patients with other diseases. Nonspecific reactions with IHA tests were found rarely with P. aeruginosa and other diverse antibacterial sera. Ten per cent of sera from patients with other diseases had reactions at low-titer levels of 1:20 to 1:40. Simultaneous "nonspecific" crossreactions in IHA and CF tests were rare. If a titer of 1: 8 in lieu of 1 :4 is used as a criterion of a significant CF reaction (Table 8) , the specificity of the procedure can be improved without any appreciable effect on its sensitivity.
The course of the serological response as determined by IHA and CF tests was similar. Antibodies were detectable in all but a few patients by the second week of disease. Significant rises in antibody titer during the early course of disease were demonstrated infrequently. Moreover, in most such cases, titer rises were fortuitously demonstrated during the course of study of patients with fevers of undetermined origin. The paucity of demonstrable titer rises primarily reflects the fact that, in subacute melioidosis, patients are rarely seen when initial disease signs occur. The initial signs may be mild and easily disregarded. By the time acute symptoms develop and medical attention is sought, detectable antibodies are usually present. In some cases the disease was a recurrent manifestation of previously unrecognized latent or chronic melioidosis. The high percentage of positive IHA and CF reactions in sera obtained during the first week of disease is not surprising, since the purported time of disease in most of these cases was probably specious.
By the third week of disease, high antibody titers were usually present. Persistence of antibodies was demonstrated for a large number of patients who provided serial serum samples over a 6-to 9-month period after disease onset. In a relatively small number of patients tested, antibodies were detectable from 2 to 3.5 years, and in one case as long as 7 years, after infection. Available case-history data provided no evidence that serological response of patients had prognostic significance. Persistence of titers occurred in chronic cases as well as in cases with a limited disease course. The status of the patient's infection could not be related to antibody titer.
The observed persistence of antibodies in a large proportion of cases serves to affirm the potential usefulness of the IHA and CF procedures for seroepidemiological surveys of human populations. The IHA test has been used advantageously for diagnosis of melioidosis in goats and pigs. The CF test appears to have good sensitivity in detecting antibodies in experimentally infected monkeys (13) . Its applicability to other animal species has not been established.
